8point8 Capital

8point8 Capital focuses on early-stage investments in high-growth UK businesses, primarily providing pre-seed, seed, and Series A funding. The firm's investment strategy targets companies with significant growth potential in the United Kingdom, supporting them through crucial early development stages.

One of 8point8 Capital's notable portfolio companies is Nymbl Science, which has raised $950,000 in total funding. The firm has participated in at least one seed round, demonstrating its commitment to nurturing startups in their formative phases. 8point8 Capital's approach aims to identify and support promising UK-based ventures poised for rapid expansion.